540788
ASPIRA
Start SIP
Invest Now
Start SIP in ASPIRA
Performance
- Low
- ₹59
- High
- ₹63
- 52 Week Low
- ₹50
- 52 Week High
- ₹107
- Open Price₹62
- Previous Close₹61
- Volume717
- 50 DMA₹64.27
- 100 DMA₹64.09
- 200 DMA₹63.03
Investment Returns
- Over 1 Month -2.2%
- Over 3 Month + 2.96%
- Over 6 Month -5.07%
- Over 1 Year -9.66%
Smart Investing Starts Here Start SIP with Aspira Pathlab & Diagnostics for Steady Growth!
Aspira Pathlab & Diagnostics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 42.7
- PEG Ratio
- 0.6
- Market Cap Cr
- 63
- P/B Ratio
- 4.3
- Average True Range
- 4.82
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.12
- RSI
- 43.51
- MFI
- 60.77
Aspira Pathlab & Diagnostics Financials
Aspira Pathlab & Diagnostics Technicals
EMA & SMA
Current Price
₹60.80
-0.52
(-0.85%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹63.95
- 50 Day
- ₹64.27
- 100 Day
- ₹64.09
- 200 Day
- ₹63.03
Resistance and Support
60.88
- R3 66.25
- R2 64.57
- R1 62.56
- S1 58.87
- S2 57.19
- S3 55.18
Aspira Pathlab & Diagnostics Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-10 | Quarterly Results | |
| 2025-11-12 | Quarterly Results | |
| 2025-08-12 | Quarterly Results | |
| 2025-05-16 | Audited Results | |
| 2025-02-07 | Quarterly Results |
Aspira Pathlab & Diagnostics F&O
About Aspira Pathlab & Diagnostics
- NSE Symbol
- ASPIRA
- BSE Symbol
- 540788
- Managing Director & CEO
- Dr. Pankaj J Shah
- ISIN
- INE500C01017
Similar Stocks to Aspira Pathlab & Diagnostics
Aspira Pathlab & Diagnostics FAQs
Aspira Pathlab & Diagnostics share price is ₹60 As on 14 February, 2026 | 01:18
The Market Cap of Aspira Pathlab & Diagnostics is ₹62.6 Cr As on 14 February, 2026 | 01:18
The P/E ratio of Aspira Pathlab & Diagnostics is 42.7 As on 14 February, 2026 | 01:18
The PB ratio of Aspira Pathlab & Diagnostics is 4.3 As on 14 February, 2026 | 01:18
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.